In both cases, delays can occur due to incomplete submissions, requests for additional information, or issues identified during the review process. Manufacturers can expedite their applications through various programs like the FDA’s Breakthrough Devices Program, which aims to speed up the review process for devices that provide significant benefits over existing options.